Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001607854-16-000003
Filing Date
2016-10-06
Accepted
2016-10-06 16:53:16
Documents
1
Effectiveness Date
2016-10-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9984
  Complete submission text file 0001607854-16-000003.txt   11008
Mailing Address 19 BLACKSTONE STREET CAMBRIDGE MA 02139
Business Address 19 BLACKSTONE STREET CAMBRIDGE MA 02139 617-714-9620
Lysosomal Therapeutics, Inc. (Filer) CIK: 0001607854 (see all company filings)

EIN.: 454015802 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-272003 | Film No.: 161925308